Tergus Lauded by Frost & Sullivan for Its Full-spectrum CRO Services for Therapeutics in Dermatology
Frost & Sullivan
MARCH 8, 2021
. “The company has established itself as a strategic partner with flexible development capabilities, growing both organically as well as through acquisitions.” The company works with customers across business verticals such as generics and novel drugs, driven mainly by large pharma, specialty pharma, and biotech startups.
Let's personalize your content